Literature DB >> 3158724

Coincidental fluctuations of humoral immunity and clinical progression in a patient with subacute sclerosing panencephalitis.

B Friis, B Bloch, V Faber, A Salmi, B Ziola.   

Abstract

Serum and cerebrospinal fluid were obtained from a 6-year-old male with subacute sclerosing panencephalitis (SSPE). Specimens were collected over a 9-month period beginning in the unusually acute phase and ending in a more quiescent phase of the disease. Immune complexes, auto-antibodies and viral antibodies were measured by radio-immunoassays. Fluctuations in these humoral immune parameters coincided with cessation of the acute phase of this disease. The results show that neurological changes in SSPE patients can be reflected in immune responses within both the peripheral circulation and the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158724     DOI: 10.1007/bf00314042

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

2.  Measles-virus-specific immunoglobulin-M response in subacute sclerosing panencephalitis.

Authors:  W R Kiessling; W W Hall; L L Yung; V ter Meulen
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

3.  Porcine C1q and the solid-phase immunoassay of human immune complexes.

Authors:  B Ziola; A Salmi; K Penttinen
Journal:  J Immunol Methods       Date:  1982-03-26       Impact factor: 2.303

4.  Measles virus-specific IgM antibodies and IgM-class rheumatoid factor in serum and cerebrospinal fluid of subacute sclerosing panencephalitis patients.

Authors:  B Ziola; A Salmi; M Panelius; P Halonen
Journal:  Clin Immunol Immunopathol       Date:  1979-08

5.  IgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients.

Authors:  B Ziola; M Reunanen; A Salmi
Journal:  J Neurol Sci       Date:  1981-07       Impact factor: 3.181

6.  Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay.

Authors:  E M Salonen; A Vaheri; J Suni; O Wager
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

7.  Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.

Authors:  A Salmi; B Ziola; M Reunanen; I Julkunen; O Wager
Journal:  Acta Neurol Scand       Date:  1982-07       Impact factor: 3.209

8.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis.

Authors:  A A Salmi; E Norrby; M Panelius
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

10.  Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments.

Authors:  B H Toh; A Yildiz; J Sotelo; O Osung; E J Holborow; F Kanakoudi; J V Small
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

View more
  2 in total

1.  Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue.

Authors:  D R Carrigan; K K Knox
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Serum antibodies to central nervous system antigens: an analysis of their relation with different human neurologic disorders.

Authors:  P Huppi; L Bologa; N Herschkowitz
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.